Evidence map›Paper›PMID 31317426›Full record

ArticleClinical rheumatology2020

Association of simple hematological parameters with disease manifestations, activity, and severity in patients with systemic sclerosis.

Müçteba Enes Yayla, Ufuk İlgen, İlyas Ercan Okatan, Emine UsluYurteri, Murat Torgutalp, Ayşe Bahar Keleşoğlu Dinçer, Emine Gözde Aydemir Gülöksüz, Serdar Sezer, Tahsin Murat Turgay, Gülay Kınıklı and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. The Neutrophil-to-lymphocyte ratio as a diagnostic and prognostic biomarker in pulmonary hypertension: A systematic review.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Müçteba Enes YaylaDepartment of Rheumatology, Faculty of Medicine, Ankara University, Sıhhıye, Ankara, Turkey. enesyayla@hotmail.com.ORCID http://orcid.org/0000-0002-5998-6703
Ufuk İlgenDepartment of Rheumatology, Faculty of Medicine, Trakya University, Edirne, Turkey.
İlyas Ercan OkatanDepartment of Rheumatology, Faculty of Medicine, Ankara University, Sıhhıye, Ankara, Turkey.
Emine UsluYurteriDepartment of Rheumatology, Faculty of Medicine, Ankara University, Sıhhıye, Ankara, Turkey.
Murat TorgutalpDepartment of Rheumatology, Faculty of Medicine, Ankara University, Sıhhıye, Ankara, Turkey.
Ayşe Bahar Keleşoğlu DinçerDepartment of Rheumatology, Faculty of Medicine, Ankara University, Sıhhıye, Ankara, Turkey.
Emine Gözde Aydemir GülöksüzDepartment of Rheumatology, Faculty of Medicine, Ankara University, Sıhhıye, Ankara, Turkey.
Serdar SezerDepartment of Rheumatology, Faculty of Medicine, Ankara University, Sıhhıye, Ankara, Turkey.
Tahsin Murat TurgayDepartment of Rheumatology, Faculty of Medicine, Ankara University, Sıhhıye, Ankara, Turkey.
Gülay KınıklıDepartment of Rheumatology, Faculty of Medicine, Ankara University, Sıhhıye, Ankara, Turkey.
Aşkın AteşDepartment of Rheumatology, Faculty of Medicine, Ankara University, Sıhhıye, Ankara, Turkey.
Ankara University · TRTrakya University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

INTRODUCTION/

objectivesNeutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), mean platelet volume (MPV), and red cell distribution width (RDW) may potentially reflect inflammatory status in systemic autoimmune diseases. The aim of this study is to investigate the association between these proposed markers and disease manifestations, activity, and severity in systemic sclerosis (SSc).

methodWe conducted a cross-sectional study of 69 systemic sclerosis (SSc) patients and 50 healthy volunteers in a single center. Adult patients with SSc and healthy controls were compared in terms of NLR, MLR, MPV, RDW, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP). Venous blood samples were drawn after at least 8 h of fasting in the morning. Extension of skin fibrosis was evaluated by using modified Rodnan skin score (mRSS). Disease severity and activity were assessed by Medsger disease severity and European Scleroderma Trials and Research Group (EUSTAR) disease activity scores, respectively. Associations of disease manifestations, clinical, laboratory, and capillaroscopic findings, mRSS, and the disease activity and severity scores with the proposed hematological markers were evaluated. Multiple regression models were generated for significant associations.

resultsThe neutrophil number was higher (p = 0.004) and lymphocyte number was lower (p < 0.001) in SSc group compared to controls. SSc group also had higher NLR, MLR, and RDW. In multiple logistic regression, only the NLR (regression coefficient = 3.49, p = 0.031) and CRP (regression coefficient = 0.17, p = 0.037) remained significantly different between SSc and healthy control groups (Cox and Snell R

conclusionsGlobally available and inexpensive hematological tests, particularly the NLR and MLR, may be associated with vascular and cutaneous manifestations as well as disease activity and severity in SSc.Key Points• Monocyte count itself independently predicted higher activity and severity scores in SSc.• Globally available and inexpensive hematological markers, particularly the NLR and MLR, may have an association with vascular and cutaneous manifestations as well as disease activity and severity in patients with SSc.

Indexed as

AdultBiomarkersBlood PlateletsBlood SedimentationCase-Control StudiesC-Reactive ProteinCross-Sectional StudiesErythrocyte IndicesFemaleHumansLeukocyte CountLinear ModelsLogistic ModelsLymphocytesMaleMean Platelet VolumeBiomarkersC-Reactive ProteinComplete blood countMLRMonocyte-to-lymphocyte ratioNeutrophil-to-lymphocyte ratioNLRSclerodermaSystemic sclerosis

Identifiers

PMID31317426
OpenAlexW2962391519

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.